Lausanne’s new hub for cancer research will celebrate its opening by welcoming 500 international scientists to an event discussing the future of cancer therapy.

The 2016 ISREC (The Swiss Institute for Experimental Cancer Research) Inaugural Symposium will take place at the Swiss Cancer Center Lausanne, September 7-10. The four-day symposium will focus on broad themes – horizons – in cancer biology and therapy.

The event will also inaugurate the new multi–institutional Swiss Cancer Center Lausanne (SCCL), which leverages complementary expertise from its partner institutions: the University Hospital & Medical Center (CHUV) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), Ludwig Cancer Research (Ludwig), and the ISREC Foundation, along with the University Hospital & Medical Center (HUG) of the University of Geneva (UNIGE), and the Swiss Institute for Bioinformatics (SIB).

The SCCL fosters innovation by integrating translational and clinical cancer research. It combines the expertise of bioengineers, immune engineers, bioinformaticians, chemists, molecular biologists, mouse modelists, cancer biologists, imaging experts, cancer therapy investigators and clinician-scientists in the same environment, providing opportunities for discovery and clinical development.

The venue lies within the heart of the Western Switzerland’s Health Valley, home to 450 biotechs, 300 medtech companies, 500 biomedical research laboratories and 8 incubators, ensuring it will be a catalyst in fostering innovation in cancer medicine in the BioAlps network, the Life Science cluster of Western Switzerland.

Lausanne Tourism & Convention Bureau Business Development Manager Gérald Howard, said: “The Swiss Cancer Centre offers the perfect context and infrastructure for the event and we hope that all the delegates enjoy the hospitality and cultural attractions of the city during their visit.”

The Symposium will see basic, translational, and clinical cancer scientists present their latest results, alongside opportunities to interact and share knowledge with fellow cancer researchers.

Featured image: The University Hospital & Medical Center (CHUV) of the University of Lausanne

(via AMI)